{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1508363690",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/975559344"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1508363690",
  "code": "3A51.6",
  "source": "http://id.who.int/icd/entity/1508363690",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Haemoglobin D disease"
  },
  "definition": {
    "@language": "en",
    "@value": "Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia."
  },
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1426960900"
  ],
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/1148519290"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Haemoglobin D disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Punjab disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Los Angeles disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hb D Los Angeles disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hb D Punjab disease"
      }
    }
  ]
}